London — European shares on Wednesday shrugged off heavy losses for US tech stocks and a major drugmaker delaying testing of a coronavirus vaccine, as investors kept faith in an economic recovery from the coronavirus pandemic.

The broad Euro Stoxx 600 gained 0.7% in early trading, steadying after hefty declines a day earlier on a rout of tech shares, a key drivers of the stunning recovery for global stocks from coronavirus-induced lows...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.